Evidence map›Paper›PMID 29755470›Full record

ArticleFrontiers in immunology2018

CD36 Shunts Eicosanoid Metabolism to Repress CD14 Licensed Interleukin-1β Release and Inflammation.

Karina F Zoccal, Luiz G Gardinassi, Carlos A Sorgi, Alyne F G Meirelles, Karla C F Bordon, Isaias Glezer, Palmira Cupo, Alessandra K Matsuno, Valdes R Bollela, Eliane C Arantes and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. CD14 signaling mediates lung immunopathology and mice mortality induced by Achromobacter xylosoxidans.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Immunological Responses to Envenomation.Frontiers in immunology · 2021
    Review
  12. Interleukin-1 receptor-induced PGENature communications · 2020
    Article
  13. Article
  14. Immunomodulatory activity of hyaluronidase is associated with metabolic adaptations during acute inflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2020
    Article
  15. Medicines (Basel, Switzerland) · 2019
    Article
  16. Article
  17. Plasma Eicosanoid Profile inFrontiers in immunology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Karina F ZoccalDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Luiz G GardinassiDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Carlos A SorgiDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Alyne F G MeirellesDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Karla C F BordonDepartamento de Física e Química, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Isaias GlezerDepartamento de Bioquímica, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Palmira CupoDepartamento de Puericultura e Pediatria, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Alessandra K MatsunoDepartamento de Puericultura e Pediatria, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Valdes R BollelaDepartamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Eliane C ArantesDepartamento de Física e Química, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Francisco S GuimarãesDepartamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Lúcia Helena FaccioliDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Universidade de São Paulo · BRUniversidade de Ribeirão Preto · BRUniversidade Federal de São Paulo · BR

Funding

UCD Mutant Mouse Regional Resource CenterU42OD012210 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2012 to 2026
$29.2M
NIH HHS U42 OD012210
6 · The paper itself

Abstract

Interleukin (IL)-1β is a potential target for treatment of several inflammatory diseases, including envenomation by the scorpion

Indexed as

AdultAnimalsCD36 AntigensDisease Models, AnimalEicosanoidsFemaleHealthy VolunteersHumansInterleukin-1betaLeukocytes, MononuclearLipopolysaccharide ReceptorsMaleMiceMice, Inbred C57BLMice, KnockoutMiddle AgedCD14 protein, humanCd14 protein, mouseCD36 AntigensCD36 protein, humanCd36 protein, mouseEicosanoidsIL1B protein, humanInterleukin-1betaLipopolysaccharide ReceptorsScorpion VenomsCD14 receptorCD36 receptorcyclic adenosine monophosphateinterleukin-1βleukotriene B4prostaglandin E2venom

Identifiers

PMID29755470
PMCPMC5934479
OpenAlexW2800028184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.